Cargando…

Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model

Fibromyalgia (FM) is a chronic, widespread pain disorder generally of a non-inflammatory nature with many known affective and cognitive comorbidities. There is promise in the implementation of hyperbaric oxygen therapy (HBO(2)) for alleviating FM pain and comorbidities, despite no work investigating...

Descripción completa

Detalles Bibliográficos
Autores principales: Argenbright, Cassie M., Bland, Michelle K., Michener, Sydney L., Wilson, Judy R., Fuchs, Perry N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014544/
https://www.ncbi.nlm.nih.gov/pubmed/36937563
http://dx.doi.org/10.3389/fpain.2023.1097457
_version_ 1784907015364018176
author Argenbright, Cassie M.
Bland, Michelle K.
Michener, Sydney L.
Wilson, Judy R.
Fuchs, Perry N.
author_facet Argenbright, Cassie M.
Bland, Michelle K.
Michener, Sydney L.
Wilson, Judy R.
Fuchs, Perry N.
author_sort Argenbright, Cassie M.
collection PubMed
description Fibromyalgia (FM) is a chronic, widespread pain disorder generally of a non-inflammatory nature with many known affective and cognitive comorbidities. There is promise in the implementation of hyperbaric oxygen therapy (HBO(2)) for alleviating FM pain and comorbidities, despite no work investigating the efficacy of this treatment in prominent preclinical FM models. This project aimed to investigate the affective components, specifically anhedonia and anxiety, associated with an acidic saline model of FM in rats. We investigated the acidic saline model's ability to produce the sensory component of FM through reduced mechanical thresholds, as well as anxiety-like and avoidance behaviors through measures of open field and place escape/avoidance. We further investigated the use of pregabalin, a known FM therapeutic agent, in reducing negative sensory and affective measures within the model. Results revealed insignificant between-group differences for measures of anxiety, despite animals in the FM condition showing significantly reduced mechanical thresholds. Results further revealed that the acidic saline model was effective in increasing place escape/avoidance behavior among animals in the FM condition, with pregabalin reducing avoidance behaviors. In addition, we investigated the role of HBO(2) [two 60-minute treatments at 2.0 ATA (atmospheres absolute)] in alleviating FM-like pain, anxiety, and anhedonia in the acidic saline model, utilizing mechanical paw withdrawal thresholds, open field, and sucrose preference measures. Results revealed that the acidic saline model produced reduced thresholds indicative of FM-like pain. Data did not provide support for the presence of anxio-depressive comorbidities associated with the FM model. HBO(2) treatment did not significantly increase mechanical thresholds as expected. Future studies should seek to investigate the experimental circumstances within which the acidic saline model produces negative affect alongside hyperalgesia in order to contribute to the development of a multidimensional FM treatment methodology.
format Online
Article
Text
id pubmed-10014544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100145442023-03-16 Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model Argenbright, Cassie M. Bland, Michelle K. Michener, Sydney L. Wilson, Judy R. Fuchs, Perry N. Front Pain Res (Lausanne) Pain Research Fibromyalgia (FM) is a chronic, widespread pain disorder generally of a non-inflammatory nature with many known affective and cognitive comorbidities. There is promise in the implementation of hyperbaric oxygen therapy (HBO(2)) for alleviating FM pain and comorbidities, despite no work investigating the efficacy of this treatment in prominent preclinical FM models. This project aimed to investigate the affective components, specifically anhedonia and anxiety, associated with an acidic saline model of FM in rats. We investigated the acidic saline model's ability to produce the sensory component of FM through reduced mechanical thresholds, as well as anxiety-like and avoidance behaviors through measures of open field and place escape/avoidance. We further investigated the use of pregabalin, a known FM therapeutic agent, in reducing negative sensory and affective measures within the model. Results revealed insignificant between-group differences for measures of anxiety, despite animals in the FM condition showing significantly reduced mechanical thresholds. Results further revealed that the acidic saline model was effective in increasing place escape/avoidance behavior among animals in the FM condition, with pregabalin reducing avoidance behaviors. In addition, we investigated the role of HBO(2) [two 60-minute treatments at 2.0 ATA (atmospheres absolute)] in alleviating FM-like pain, anxiety, and anhedonia in the acidic saline model, utilizing mechanical paw withdrawal thresholds, open field, and sucrose preference measures. Results revealed that the acidic saline model produced reduced thresholds indicative of FM-like pain. Data did not provide support for the presence of anxio-depressive comorbidities associated with the FM model. HBO(2) treatment did not significantly increase mechanical thresholds as expected. Future studies should seek to investigate the experimental circumstances within which the acidic saline model produces negative affect alongside hyperalgesia in order to contribute to the development of a multidimensional FM treatment methodology. Frontiers Media S.A. 2023-03-01 /pmc/articles/PMC10014544/ /pubmed/36937563 http://dx.doi.org/10.3389/fpain.2023.1097457 Text en © 2023 Argenbright, Bland, Michener, Wilson and Fuchs. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pain Research
Argenbright, Cassie M.
Bland, Michelle K.
Michener, Sydney L.
Wilson, Judy R.
Fuchs, Perry N.
Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
title Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
title_full Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
title_fullStr Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
title_full_unstemmed Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
title_short Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
title_sort pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
topic Pain Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014544/
https://www.ncbi.nlm.nih.gov/pubmed/36937563
http://dx.doi.org/10.3389/fpain.2023.1097457
work_keys_str_mv AT argenbrightcassiem pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel
AT blandmichellek pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel
AT michenersydneyl pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel
AT wilsonjudyr pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel
AT fuchsperryn pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel